Loading…

Differentiating keratoacanthoma from squamous cell carcinoma—In quest of the holy grail

To distinguish keratoacanthomas from squamous cell carcinomas remains a diagnostic challenge in dermatopathology. Several immunohistochemical and cytogenetic markers have been evaluated; however, so far there has been no unequivocal evidence supporting practical application of any of these markers....

Full description

Saved in:
Bibliographic Details
Published in:Journal of cutaneous pathology 2020-04, Vol.47 (4), p.418-420
Main Author: Nagarajan, Priyadharsini
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To distinguish keratoacanthomas from squamous cell carcinomas remains a diagnostic challenge in dermatopathology. Several immunohistochemical and cytogenetic markers have been evaluated; however, so far there has been no unequivocal evidence supporting practical application of any of these markers. Recent studies have evaluated the composition of tumor‐associated immune infiltrate, in particular the number and distribution of CD123‐positive plasmacytoid dendritic cells in making this distinction; but these cells also do not appear to be a consistent biomarker in distinguishing keratoacanthoma from squamous cell carcinoma.
ISSN:0303-6987
1600-0560
DOI:10.1111/cup.13640